HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack ...
Twelve-lead ECGs, although standard in hospitals, can be bulky and impractical for home use. On the other hand, Apple Watch’s ECG app is easy to use, but it is limited in what it can detect because it ...
(RTTNews) - HeartBeam, Inc. (BEAT), a medical technology company, announced Wednesday that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Company's groundbreaking ...
AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...
A new algorithm developed by researchers at the Mayo Clinic can effectively detect patients with a dangerous heart dysfunction using data gathered by an Apple Watch. A large trial is now underway ...
Days of greater local ambient ozone pollution coincided with excess hospital admissions for cardiovascular disease in China. (European Heart Journal) FDA and CDC officials sent a letter to Florida ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results